alexa Amphetamines: Potent Recreational Drug of Abuse
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Amphetamines: Potent Recreational Drug of Abuse

Md. Sahab Uddin1*, Mohammad Abu Sufian1, Md. Tanvir Kabir2, Md. Farhad Hossain3, Md.Nasrullah1, Israt Islam4, Abdullah Al Mamun1, Md.Tanjir Islam1and Sayema Khanum1

1Department of Pharmacy, Southeast University, Dhaka, Bangladesh

2Department of Pharmacy, BRAC University, Dhaka, Bangladesh

3Department of Physical Therapy, Graduate School of Inje University, Gimhae, Korea

4Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh

*Corresponding Author:
Md. Sahab Uddin
Department of Pharmacy, Southeast University
Dhaka, Bangladesh
Tel: +880 1710220110
E-mail: [email protected]
[email protected]

Received date: March 10, 2017; Accepted date: June 14, 2017; Published date: June 21, 2017

Citation: Uddin MS, Sufian MA, Kabir MT, Hossain MF, Nasrullah M, et al. (2017) Amphetamines: Potent Recreational Drug of Abuse. J Addict Res Ther 8:330. doi:10.4172/2155-6105.1000330

Copyright: © 2017 Uddin MS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Amphetamines are central nervous system (CNS) stimulants and belong to psychoactive drugs that affect chemicals in the brain, nerves and exert a constant contribution to hyperactivity and impulse control. The communal group of amphetamines comprises amphetamine, dextroamphetamine and methamphetamine. Amphetamines show its action on the mesolimbic dopaminergic reward system by inducing release of dopamine and to some extent norepinephrine, in the synaptic clefts of the nucleus accumbens and other terminal areas. They offer not only a sense of euphoric state, but also addiction. Amphetamines are frequently prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults, narcolepsy and obesity. At therapeutic doses, amphetamine causes emotional and cognitive effects such as euphoria, change in desire for sex, increased wakefulness, improved cognitive control, etc. The balance of benefit/risk is the main challenge for its clinical use. When overused these medications can be highly addictive, are often diverted from the user to be used as recreational drugs. Adverse effects include anxiety, aggression, headache, insomnia, hyperactivity, palpitations, increased breathing rate, increased blood pressure, tachycardia, arrhythmia, dilated pupils, paranoia, etc. However, at large doses, these drugs may impair cognitive function and induce rapid muscle breakdown. Even higher doses may give rise to hallucinations, paranoia, psychosis and potentially lifethreatening conditions such as convulsions, stroke, kidney failure, etc. The furthermost serious health implications of amphetamine resulting from chronic use are dependence, considered by compulsive drug-seeking and drug use and a phenomenon notorious as amphetamine psychosis. Therefore the objective of this study was to explore the functions of the amphetamines as recreation drug of abuse.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords